For law firms investing in paid social media advertising, Facebook remains one of the most powerful platforms available. With nearly three billion monthly active users and a targeting engine built on layers of demographic, behavioral, and interest data, the platform offers reach that no other social channel can match.
But reach is not the same as precision. And for law firms, precision is everything. The difference between a successful Facebook campaign and a wasted budget often comes down to one question: can Facebook actually identify the people you need to reach?
The answer depends entirely on the type of litigation you are marketing.
Where Facebook Targeting Excels: Automotive and Product Defect Litigation
Facebook’s advertising platform has long been one of the most effective tools for reaching vehicle owners. Through partnerships with data aggregators like IHS Automotive (formerly Polk) and Oracle (which acquired Datalogix), Meta built behavioral targeting categories rooted in real-world data, including DMV registration records, purchase transaction histories, and warranty information.
These partnerships allowed advertisers to target Facebook users based on the make, model, style, and age of the vehicle in their household, whether they purchased or leased, and even whether they were likely to be in the market for a new vehicle within the next 180 days.
Although Meta removed direct access to third-party Partner Categories in 2018 following the Cambridge Analytica scandal, the platform’s behavioral and interest-based targeting still allows advertisers to reach users who engage with automotive content, follow specific vehicle brands, and exhibit in-market shopping behavior. Combined with custom audiences, lookalike modeling, and retargeting through the Meta Pixel, Facebook remains a highly effective platform for automotive defect and recall litigation.
The reason is simple. Facebook can observe and infer vehicle ownership. There are verifiable data signals tied to that behavior, from registration records to brand engagement to purchase history. When a law firm runs a Facebook campaign targeting owners of a recalled vehicle, the platform has real mechanisms to put that ad in front of the right people.
This same principle applies to other litigation categories where Facebook can identify the target audience through observable behavior. Product liability cases involving widely purchased consumer goods, defective household appliances, or recalled children’s products all benefit from Facebook’s ability to target users based on purchase behavior, brand affinity, and interest signals.
Litigation tied to life events that users self-report on the platform, such as employment status for wage and hour claims, parental status for cases involving children’s products, or personal injury claims targeting workers in certain professions also align well with Facebook’s data model.
Where Facebook Targeting Breaks Down: Pharmaceutical Litigation
Now consider a pharmaceutical liability campaign. Your firm is representing claimants who took a specific prescription medication and suffered adverse health effects. You need to reach people who used that drug.
Facebook cannot do this.
There is no registration database for prescription drug use. There is no behavioral signal on Facebook that tells the platform whether a user filled a specific prescription. Users do not self-report their medication history in their profiles. And unlike automotive data, which can be validated against DMV records and purchase transactions, prescription drug use is protected health information governed by HIPAA and a web of federal and state privacy regulations.
Meta itself prohibits advertisers from targeting users based on specific health conditions or prescription medication use. The platform’s health and wellness advertising policies restrict the use of health-related data for audience targeting, and campaigns that attempt to build audiences around medical conditions risk account suspension. In January 2025, Meta implemented additional restrictions on healthcare data within its ad platform, further limiting how advertisers can use health-related signals for targeting and optimization.
This means that a Facebook campaign for pharmaceutical litigation is fundamentally different from an automotive defect campaign. You are not reaching people the platform has identified as likely claimants. You are broadcasting a message to a broad demographic audience and hoping that the people who qualify happen to see it and self-select. That is a much less efficient model, and it is why many law firms report that their Facebook campaigns for pharmaceutical cases generate high volumes of leads but very low qualification rates.
The same challenge applies to other litigation categories where the qualifying event is invisible to Facebook. Toxic exposure cases, occupational illness claims, medical device litigation tied to specific implants or procedures, and environmental contamination lawsuits all involve claimant populations that Facebook simply cannot identify through its available data.
What This Means for Your Firm’s Paid Search Strategy
None of this means that Facebook is useless for pharmaceutical or health-related litigation. It can still serve as an awareness and demand generation tool, particularly when paired with strong landing pages, intake screening, and retargeting sequences. But it should not be treated as a precision targeting platform for these case types the way it can be for automotive defects, product recalls, or consumer product litigation.
The firms that get the best results from Facebook advertising are the ones that match the platform’s strengths to the right litigation categories and invest in other channels, such as Google Ads, SEO, and programmatic display, for case types where Facebook’s targeting cannot deliver qualified leads at scale.
Understanding this distinction is not just a matter of marketing theory. It is the difference between a campaign that generates thousands of signed cases and one that burns through budget producing leads your intake team cannot convert.
The Abbery’s Experience with Facebook Ads for Law Firms
The Abbery has managed Facebook advertising campaigns for law firms for more than 17 years, and our work in automotive defect litigation demonstrates exactly what is possible when the platform’s targeting capabilities align with the right case type.
Our campaigns for the law firm of Heygood, Orr & Pearson, including Facebook and Google Ads initiatives for Chevy Bolt battery defect lawsuits and Jeep hybrid battery lawsuits, generated thousands of clients for the firm. These results were possible because Facebook’s data model allowed us to put ads in front of the people most likely to own the affected vehicles.
Whether your firm is evaluating Facebook for the first time or trying to figure out why an existing campaign is underperforming, the answer often starts with the same question: can the platform actually find the people you need to reach?
If you would like to talk through your firm’s paid advertising strategy and find out which platforms and approaches are the best fit for your case types, contact The Abbery so we can talk about your firm’s marketing goals. We will give you an honest assessment of where Facebook fits into your marketing plan and where your budget would be better spent elsewhere.